Previous 10 | Next 10 |
908 Devices (NASDAQ: MASS) was a standout healthcare stock on Tuesday. The company's shares bounced more than 15% higher after it unveiled its latest set of quarterly results. 908 Devices, a niche healthcare equipment maker that specializes in mass spectrometry instruments, ...
Gainers: Voyager Therapeutics (NASDAQ:VYGR) +22%. 908 Devices (NASDAQ:MASS) +16%. Viemed Healthcare (NASDAQ:VMD) +10%. Cara Therapeutics (NASDAQ:CARA) +9%. Neuronetics (NASDAQ:STIM) +9%. Losers: Alector (NASDAQ:ALEC) -19%. Can-Fite BioPharma (NYSE:CANF)...
908 Devices Inc. (MASS) Q4 2021 Earnings Conference Call March 7, 2022, 4:30 PM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Co-Founder and CEO Joe Griffith - Chief Financial Officer Conference Call Participants Dustin Scaringe - Blair Puneet Souda - SVB Leerink Dan A...
Image source: The Motley Fool. 908 Devices Inc. (NASDAQ: MASS) Q4 2021 Earnings Call Mar 07, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: 908 Devices Inc. (MASS) Q4 2021 Earnings Call Transcript
Gainers: Rubius Therapeutics (NASDAQ:RUBY) +13%. Clarus Corporation (NASDAQ:CLAR) +10%. 908 Devices (NASDAQ:MASS) +6%. Velodyne Lidar (NASDAQ:VLDR) +3%. Golar LNG Limited (NASDAQ:GLNG) +3%. Losers: Rover Group (NASDAQ:ROVR) -13%. ThredUp (NASDAQ:TDUP) -10%. Immersio...
908 Devices press release (NASDAQ:MASS): Q4 GAAP EPS of -$0.12 beats by $0.04. Revenue of $15.8M (+177.2% Y/Y) beats by $0.67M. For further details see: 908 Devices GAAP EPS of -$0.12 beats by $0.04, revenue of $15.8M beats by $0.67M
2021 revenue increases 57% year over year 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter and full year ended December 31, 2021. ...
BATL, CLAR, DRRX, EARN, IDT, IEA, IPI, LFMD, MASS, ROCC, VMD For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Monday's close
908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Tony J. Hunt, President and CEO, Repligen Corporation (Nasdaq: RGEN), to serve on its Board of Directors effective immediately....
908 Devices Inc. (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, March 7, 2022. Company manag...
News, Short Squeeze, Breakout and More Instantly...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately. Ms....
Updated technology enables first responders to identify and quantify approximately 5,000 substances in mere seconds for a swift and definitive response 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced an ...
2024-06-01 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...